Biotech - Spark Newswire

2 minute read

TG Therapeutics Highlights Presentation Of TG-1701 Data At International Congress On Malignant Lymphoma

Today, 6:34 AM

TG Therapeutics, Inc. (NASDAQ:TGTX), today announced data from two presentations evaluating TG-1701, the Company's investigational once-daily, oral BTK inhibitor, presented today during the 16th International

TGTX

1 minute read

Registration Statement Related To Cleveland BioLabs-Cytocom Merger Declared Effective By SEC

By Vandana Singh

Today, 6:34 AM

Cleveland BioLabs Inc (NASDAQ:CBLI) says that the SEC registration statement regarding the previously announced merger with Cytocom Inc was declared effective…

CBLI

3 minute read

ADC Therapeutics Highlights Presentation Of Updated ZYNLONTA Clinical Data At 16th Annual International Conference On Malignant Lymphoma

By Bill Haddad

Today, 6:34 AM

LOTIS-2 updated results demonstrate durable responses of ZYNLONTA™ with median duration of response of 13.4 months in heavily pre-treated patients with relapsed or refractory DLBCL LOTIS-3 updated Phase 1

ADCT

1 minute read

BioNTech Starts Dosing In Mid-Stage Melanoma Vaccine Trial

By Vandana Singh

Today, 6:34 AM

BioNTech SE (NASDAQ:BNTX) has dosed the first patient in its Phase 2 trial evaluating the BNT111 cancer vaccine. The study evaluates…

BNTX

1 minute read

Bristol Myers Inks Licensing Pact For Eisai’s Folate Receptor ADC Drug, Lays Out Over $3B For Rights

By Vandana Singh

Today, 6:34 AM

Eisai Co Ltd (OTC:ESALY) and Bristol-Myers Squibb Co (NYSE:BMY) have entered into an exclusive global strategic collaboration agreement for the co-development and co-commercialization…

BMY

4 minute read

Iveric Bio To Present Zimura GATHER2 Enrollment And Retention Updates And New GATHER1 Post-Hoc Analyses Today At Dry Age-Related Macular Degeneration Virtual Symposium

By Bill Haddad

Today, 6:34 AM

- GATHER2 Enrollment Nears Completion; Timeline Accelerated to Late July of this Year - - GATHER2 Retention Exceeding Expectations; with Injection Fidelity Rate Target for GATHER2 Greater

ISEE

1 minute read

Athira Pharma Stock Plummets After CEO Placed On Temporary Leave

By Vandana Singh

Today, 6:34 AM

Athira Pharma Inc (NASDAQ:ATHA) CEO Leen Kawas has been placed on temporary leave until the company completes a review “stemming from…

ATHA

1 minute read

Geron Stock Trading Is Higher On Reinforcing Imetelstat’s Approach For Myelofibrosis Treatment, With Data Publication In Journal

By Vandana Singh

Today, 6:34 AM

Geron Corporation (NASDAQ:GERN) stock is trading higher during the premarket in reaction to data publication from the IMbark Phase 2…

GERN

2 minute read

Orphazyme Wild Party At Risk As FDA Rejects Its Rare Neurodegenerative Disease Drug

By Shanthi Rexaline

Today, 6:34 AM

Orphazyme A/S (NASDAQ: ORPH) shares, which have been extremely volatile of late, could come under pressure Friday

CYTR

1 minute read

Tesla Partner CureVac Says Will Find ‘Sweet Spot’ For COVID-19 Vaccine Despite Disappointing Data

By Rachit Vats

Today, 6:34 AM

CureVac N.V.’s (NASDAQ: CVAC) Chief Financial Officer Pierre Kemula is optimistic its COVID-19 vaccine could still be offered to certain age groups or as a booster, the Financial Times reported o

CVAC